Inquiry
Form loading...
Pharmaceutical Intermediates News

Pharmaceutical Intermediates News

Fluorescent Splendor, Full-Chain Empowerment—Shengyu Chemical's Diversified D...

Fluorescent Splendor, Full-Chain Empowerment—Shengyu Chemical's Diversified D...

2025-11-24
Recently, Zhejiang Shengyu Chemical Co., Ltd. (hereinafter referred to as "Shengyu Chemical") officially launched its featured fluorescent dye product matrix. Centered on more than ten high-performance fluorescent dyes such as Yellow II 100%, Orange 2RF 100%, and Red G 100%, the company simulta...
view detail
Zhejiang Shengyu Chemical: A Trusted Source for High-Quality L-Proline

Zhejiang Shengyu Chemical: A Trusted Source for High-Quality L-Proline

2026-01-23
Introductory Paragraph: Zhejiang Shengyu Chemical is pleased to position itself as a key manufacturer in the global L-Proline market. As a versatile amino acid with growing demand across pharmaceuticals, cosmetics, and food & beverage industries, L-Proline ...
view detail

China’s Pharmaceutical Intermediates Market Expected to Reach RMB 290 Billion...

2026-08-10
According to the "2025‑2030 China Pharmaceutical Intermediates Industry Market Development Monitoring and Investment Strategy Report" published by the China Business Industry Research Institute, the Chinese pharmaceutical intermediates market reached RMB 2...
view detail
Multiple API Manufacturers Obtain EU GMP and CEP Certifications, Accelerating...

Multiple API Manufacturers Obtain EU GMP and CEP Certifications, Accelerating...

2026-09-01
In terms of global API expansion, several companies have recently made significant progress. EU GMP Certification: On July 31, a domestic API manufacturer announced that it had received GMP certificates from the Hamburg Health Authority in Germany for its h...
view detail
Domestic Firm Achieves Breakthrough in Bio‑based Mass Production of Key Inter...

Domestic Firm Achieves Breakthrough in Bio‑based Mass Production of Key Inter...

2026-09-04
With the global popularity of GLP‑1 class drugs such as semaglutide and tirzepatide for diabetes and weight management, domestic supply of their core intermediates has attracted increasing attention. Recently, a domestic biotechnology company made a major ...
view detail